Biological role of Interleukin 33 and its importance in pathophysiology of cardiovascular system

COMMENTARY ON THE LAW

Biological role of Interleukin 33 and its importance in pathophysiology of cardiovascular system

Agnieszka Czyżewska-Buczyńska 1 , Natalia Żuk 1 , Katarzyna Romanowska-Micherda 1 , Wojciech Witkiewicz 2

1. Wojewódzki Szpital Specjalistyczny we Wrocławiu, Ośrodek Badawczo-Rozwojowy
2. Wojewódzki Szpital Specjalistyczny we Wrocławiu, Ośrodek Badawczo-Rozwojowy, Oddział Chirurgii Ogólnej, Naczyniowej i Onkologicznej

Published: 2014-06-17
DOI: 10.5604/17322693.1109218
GICID: 01.3001.0003.1257
Available language versions: en pl
Issue: Postepy Hig Med Dosw 2014; 68 : 834-841

 

Abstract

Interleukin 33 (IL-33) is a member of the IL-1 cytokin family. It is expressed by various cells and tissues, mainly epithelial and endothelial cells. It is a cytokine with dual function. It may act both as a traditional cytokine and as intracellular nuclear factor, functioning as transcription regulator. Its biological effect via interaction with membrane-bound ST2 receptor and IL-1 receptor accessory protein (IL-1RAcP) is associated with the induction of Th2-type immune response and IL-5 and IL-13 synthesis.IL-33 has a strong immunoregulatory properties. Depending on the type of activated cells, microenvironment, and costimulatory factors, IL-33 can act either as a pro- or anti-inflammatory cytokine. Recent studies indicate various protective effect of IL-33/ST2 sygnaling in atherosclerosis, obesity, disorders in glucose homeostasis and in heart diseases. The paper presents current state of knowledge about the structure and biological function of IL-33 and its receptor ST2, with particular emphasis on its role in pathophysiology of cardiovascular system.

Full text

Skip to content